Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhu, Min ^a   Gong, Xue ^a   Hu, Yonghong ^c   Ou, Weijun ^b   Wan, Yakun ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b Jiangsu Nanobody Engineering and Research Center   (China)

^c NANJING TECH UNIVERSITY   (China)

Author keywords

Biotinylation; Directional; Influenza H5N1 virus; Nanobody; Streptavidin

Indexed keywords

NANOBODY; BIOTIN; STREPTAVIDIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY COMBINING SITE; ARTICLE; BACTRIAN CAMEL; BIOPANNING; BIOSENSOR; BIOTINYLATION; CONTROLLED STUDY; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IN VIVO STUDY; INFLUENZA A VIRUS (H5N1); LIMIT OF DETECTION; MOLECULAR WEIGHT; NONHUMAN; RAPID TEST; RECOMBINANT PLASMID; SERUM; VIRUS ATTACHMENT; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS PARTICLE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; BIOTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; SINGLE-DOMAIN ANTIBODIES; STREPTAVIDIN;

EID: 84988553073     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-014-0352-5     Document Type: Article

References (30)

1. Hsieh YC, Wu TZ, Liu DP, Shao PL, Chang LY, Lu CY, Lee CY, Huang FY, Huang LM: Influenza pandemics: past, present and future. J Formos Med Assoc 2006, 105:1-6.
2. Hampson AW, Mackenzie JS: The influenza viruses. Med J Aust 2006, 185:S39-S43.
3. Salomon R, Webster RG: The influenza virus enigma. Cell 2009, 136:402-410.
4. Kim JK, Negovetich NJ, Forrest HL, Webster RG: Ducks: the -Trojan horses? of H5N1 influenza. Influenza Other Respir Viruses 2009, 3:121-128.
5. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005, 79:2814-2822.
6. Uyeki TM: Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009, 49:279-290.
7. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS: Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004, 430:209-213.
8. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF: Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
9. Krauss S, Walker D, Webster RG: Influenza virus isolation. Methods Mol Biol 2012, 865:11-24.
10. Sakurai A, Takayama K, Nomura N, Munakata T, Yamamoto N, Tamura T, Yamada J, Hashimoto M, Kuwahara K, Sakoda Y, Suda Y, Kobayashi Y, Sakaguchi N, Kida H, Kohara M, Shibasaki F: Broad-spectrum detection of h5 subtype influenza a viruses with a new fluorescent immunochromatography system. PLoS One 2013, 8:e76753.
11. Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, Chaisingh A, Chamnanpood P, Chutinimitkul S, Theamboonlers A, Poovorawan Y: Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods 2008, 152:25-31.
12. Ellis JS, Smith JW, Braham S, Lock M, Barlow K, Zambon MC: Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J Clin Microbiol 2007, 45:1535-1543.
13. He Q, Velumani S, Du Q, Lim CW, Ng FK, Donis R, Kwang J: Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol 2007, 14:617-623.
14. Storch GA: Diagnostic virology. Clin Infect Dis 2000, 31:739-751.
15. Peduru Hewa TM, Tannock GA, Mainwaring DE, Harrison S, Fecondo JV: The detection of influenza A and B viruses in clinical specimens using a quartz crystal microbalance. J Virol Methods 2009, 162:14-21.
16. Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S, Tsunetsugu-Yokota Y: Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Jpn J Infect Dis 2012, 65:19-27.
17. Lauwereys M, Arbabi Ghahroudi M, Desmyter A, Kinne J, Holzer W, De Genst E, Wyns L, Muyldermans S: Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J 1998, 17:3512-3520.
18. De Meyer T, Muyldermans S, Depicker A: Nanobody-based products as research and diagnostic tools. Trends Biotechnol 2014, 32:263-270.
19. De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J, Muyldermans S, Wyns L: Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A 2006, 103:4586-4591.
20. Muyldermans S, Baral TN, Retamozzo VC, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, Stijlemans B, Tillib S, Wernery U, Wyns L, Hassanzadeh-Ghassabeh G, Saerens D: Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol 2009, 128:178-183.
21. Li H, Sun Y, Elseviers J, Muyldermans S, Liu S, Wan Y: A nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitonin. Analyst 2014, 139:3718-3721.
22. Ma L, Sun Y, Kang X, Wan Y: Development of nanobody-based flow injection chemiluminescence immunoassay for sensitive detection of human prealbumin. Biosens Bioelectron 2014, 61:165-171.
23. De Meyer T, Eeckhout D, De Rycke R, De Buck S, Muyldermans S, Depicker A: Generation of VHH antibodies against the Arabidopsis thaliana seed storage proteins. Plant Mol Biol 2014, 84:83-93.
24. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muyldermans S: Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 2001, 45:2807-2812.
25. Hmila I, Abdallah RB, Saerens D, Benlasfar Z, Conrath K, Ayeb ME, Muyldermans S, Bouhaouala-Zahar B: VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. Mol Immunol 2008, 45:3847-3856.
26. Li H, Yan J, Ou W, Liu H, Liu S, Wan Y: Construction of a biotinylated cameloid-like antibody for lable-free detection of apolipoprotein B-100. Biosens Bioelectron 2014, 64C:111-118.
27. Ditlev SB, Florea R, Nielsen MA, Theander TG, Magez S, Boeuf P, Salanti A: Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA. PLoS One 2014, 9:e84981.
28. Vincke C, Gutierrez C, Wernery U, Devoogdt N, Hassanzadeh-Ghassabeh G, Muyldermans S: Generation of single domain antibody fragments derived from camelids and generation of manifold constructs. Methods Mol Biol 2012, 907:145-176.
29. Green NM: Avidin. Adv Protein Chem 1975, 29:85-133.
30. Liszka MJ, Clark ME, Schneider E, Clark DS: Nature versus nurture: developing enzymes that function under extreme conditions. Annu Rev Chem Biomol Eng 2012, 3:77-102.